FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia
Go back to FDA Posts Briefing Documents for Advisory Meeting Reviewing sNDA for EXPAREL® as a Nerve Block for Regional Analgesia| PACIRA (NASDAQ: PCRX) | Delayed: 25.95 -0.4 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.35 | 52 Week High | $80.25 | |||
| Open | $25.98 | 52 Week Low | $30.25 | |||
| Day High | $26.41 | P/E | N/A | |||
| Day Low | $25.68 | EPS | $-2.08 | |||
| Volume | 49,426 | |||||
| PACIRA (NASDAQ: PCRX) | Delayed: 25.95 -0.4 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $26.35 | 52 Week High | $80.25 | |||
| Open | $25.98 | 52 Week Low | $30.25 | |||
| Day High | $26.41 | P/E | N/A | |||
| Day Low | $25.68 | EPS | $-2.08 | |||
| Volume | 49,426 | |||||

